Rigorous, effective analytical testing is key in the oral thin film drug development and manufacturing lifecycle because this testing is used to verify control of drug chemistry. It can help identify barriers that prevent movement to the next phase in the development process. That's why it's critical to have efficient, accurate and high-quality analytical support for your oral thin film testing requirements. CD Formulation helps you design, develop, implement and manage an effective, safe and secure analytical testing program for an oral thin film product.
Fig.1 Characterization of oral films. (Samaneh Alaei, et al., 2021)
Our oral thin film analytical testing involves analyzing various properties and attributes of the thin film formulation to ensure its quality, performance, and suitability for drug delivery.
Fig.2 Our Oral Thin Film Analytical Testing Capabilities. (CD Formulation)
Physical characterization of the thin film includes organoleptic, thickness, weight, flexibility, and surface pH, which can impact the disintegration and dissolution of the thin film, as well as its administration.
We usually use techniques such as chromatography and spectroscopy to perform oral thin film chemical characterization. This includes analyzing the composition of the thin film, including active pharmaceutical ingredients, excipients, and any potential impurities or degradation products.
We have professional mechanical performance evaluation tools, evaluating mechanical properties such as tensile strength, elongation at break, adhesion strength, etc., which can provide insight into the film's robustness, durability, and ability to adhere to the oral mucosa.
Analyzing the microstructure and surface morphology of the thin film can help understand its uniformity, smoothness, and potential interactions with the oral cavity.
Assessing the release profile of the active ingredients from the oral thin film is critical for understanding its drug delivery behavior and ensuring the desired pharmacokinetic profile.
Characterizing the in vitro dissolution behavior and in vivo performance of the oral thin film can provide insight into its bioavailability, onset of action, and overall therapeutic effectiveness.
We provide our customers with batch release testing for raw materials, active pharmaceutical ingredients (APIs), and final products, including but not limited to assay, impurities, dissolution, content uniformity, stability, and microbial contamination testing.
We established a unique and professional oral thin film stability testing strategy based on ICH guidelines and our analytical platform, evaluating the stability of oral thin film under various storage conditions.
We have a professional analysis and testing team that can quickly respond to your testing requirements, and we can analyze any testing during the development of oral thin film. Our testing process is as follows:
Fig.3 The Workflow of Oral Thin Film Analytical Testing. (CD Formulation)
We offer a comprehensive range of analytical testing services for oral thin films. These services are designed to ensure oral thin film quality, safety, and efficacy throughout the product development and manufacturing process.
Our comprehensive analytical testing helps you understand the development of your oral thin film and ensure it meets industry standards. If you require our oral thin film analytical testing services, please contact us by phone or email, and our colleagues will get back to you within three working days.
References